NCT00780663 2011-06-15
Quarfloxin in Patients With Low to Intermediate Grade Neuroendocrine Carcinoma
Cylene Pharmaceuticals
Phase 2 Completed
Clinical Trials
4 trialsNCT00955292 2009-08-10
Dose-escalation Study of Quarfloxin in Patients With Advanced Solid Tumors or Lymphomas
Cylene Pharmaceuticals
Phase 1 Terminated
NCT00955786 2009-08-10
Dose-escalation Study of CX-3543 in Patients With Advanced Solid Tumors or Lymphomas
Cylene Pharmaceuticals
Phase 1 Completed
NCT00485966 2008-11-05
Study Evaluating Effects of CX-3543 in Patients With Relapsed or Refractory B-Cell Chronic Lymphocytic Leukemia
Cylene Pharmaceuticals
Phase 2 Withdrawn